Adrenal Tumor Program

Yale’s Adrenal Tumor Program provides comprehensive, multidisciplinary care for patients with adrenal masses and hormone-related disorders. Our expert team—including specialists in endocrinology, endocrine surgery, oncology, radiology, cardiology, and pathology—works collaboratively to deliver accurate diagnoses and personalized treatment plans.

We evaluate and treat adrenal conditions, including benign incidentalomas, primary aldosteronism, Cushing syndrome, and pheochromocytoma. Using advanced imaging, specialized hormonal testing, and state-of-the-art surgical techniques, we ensure care is personalized for each patient.

Patients identified as high risk for primary aldosteronism often have hypertension. This “hidden” condition is treatable, and early diagnosis can reduce—or even prevent—serious cardiovascular complications.

Our program is designed to streamline the patient journey, with coordinated care pathways that support timely diagnosis, efficient treatment, and seamless follow-up. We are committed to improving outcomes, reducing complications, and enhancing quality-of-life.

Make an appointment

See our specialists Refer a patient

ALDO-Alert

ALDO-Alert, a program using Automated Longitudinal Detection of Aldosteronism with Electronic Medical Record Triggering, has launched under the direction of Courtney Gibson, MD, associate professor of surgery (endocrine surgery). The program aims to improve detection and management of primary aldosteronism by implementing an electronic health record (EHR)-based clinical decision support tool using emergency department visit records.

Primary aldosteronism (PA) is a common but underdiagnosed cause of secondary hypertension, affecting up to 30% of patients with resistant hypertension, yet fewer than 2% are screened. This gap leads to significantly higher risks of cardiovascular complications, preventable morbidity, and increased healthcare costs.

The initiative systematically identifies high-risk patients, prompts appropriate screening, and streamlines referrals for targeted treatment. By increasing early diagnosis, Dr. Gibson and colleagues seek to reduce cardiovascular events, improve quality-of-life, advance health equity among underserved populations who rely on emergency care, and ease strain on the healthcare system